Literature DB >> 8702103

The Raynaud phenomenon and interferon therapy.

A Creutzig, L Caspary, M Freund.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8702103     DOI： 10.7326/0003-4819-125-5-199609010-00025

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  Digital ischemic necrosis caused by pegylated interferon in a patient with hepatitis C.

Authors:  Jana G Hashash; Sean A Tackett; David J McAdams
Journal:  World J Gastrointest Pharmacol Ther       Date:  2011-02-06

Review 2.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

3.  Severe Raynaud syndrome induced by adjuvant interferon alfa in metastatic melanoma.

Authors:  H Husein-Elahmed; J L Callejas-Rubio; R Ortega Del Olmo; R Ríos-Fernandez; N Ortego-Centeno
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.